+
  • 6748263e6987d.jpg

Recombinant Novel Coronavirus Vaccine (Y25 Adenovirus Vector)


400 189 9806

For more product details, please contact our product experts. We look forward to your call.

Product Description

Drug name

Recombinant Novel Coronavirus Vaccine (Y25 Adenovirus Vector)

COVID-19 Vaccine (ChAdOx1-S[Recombinant])

Target population for vaccination

Individuals aged 18 years and older who are susceptible to the novel coronavirus

Functions and Applications

Following vaccination with this product, the body’s immune response is stimulated to produce antibodies against the novel coronavirus, thereby preventing disease caused by infection with the virus.

Related products



undefined

undefined